SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters

This publication has 23 references indexed in Scilit:

• Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): delivery by SV40 provides durable protection against HIV-1 and does not require selection
  Gene Therapy, 1999
• HIV-1 Regulatory/Accessory Genes: Keys to Unraveling Viral and Host Cell Biology
  Science, 1998
• Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells
  Gene Therapy, 1997
• Expression of small, therapeutic RNAs in human cell nuclei
  Gene Therapy, 1997
• Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.
  Proceedings of the National Academy of Sciences, 1993
• The transcriptional start site for a human U6 small nuclear RNA gene is dictated by a compound promoter element consisting of the PSE and the TATA box
  Nucleic Acids Research, 1992
• The role of Tat in the human immunodeficiency virus life cycle indicates a primary effect on transcriptional elongation.
  Proceedings of the National Academy of Sciences, 1991
• Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
  Cell, 1990
• Extensive variation of human immunodeficiency virus type-1 in vivo
  Nature, 1988
• Upstream elements required for efficient transcription of a human U6 RNA gene resemble those of U1 and U2 genes even though a different polymerase is used.
  Genes & Development, 1988